Action of the selective 5-HT4 receptor antagonist SB 204070A in the rat kindling model of epilepsy
✍ Scribed by Yuji Wada; Naohisa Hirao; Jun Shiraishi; Mitsuhiko Nakamura; Yoshifumi Koshino
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 894 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0893-6609
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract We reported previously that (__S__)‐5‐[3‐[(1,4‐benzodioxan‐2‐ylmethyl)amino]propoxy]‐1,3‐benzodioxole hydrochloride (MKC‐242) (3 mg kg^−1^, i.p.), a selective 5‐HT~1A~ receptor agonist, accelerated the re‐entrainment of hamster wheel‐running rhythms to a new 8 hr delayed or advanced lig
## Abstract In Parkinson's disease (PD), dyskinesia develops following long‐term treatment with 3,4‐dihydroxyphenylalanine (L‐dopa). Given the prominent role of the opioid system in basal ganglia function, nonselective opioid receptor antagonists have been tested for antidyskinetic efficacy in the
This study examined the influence of the highly selective 5-HT 1A receptor ligands, flesinoxan, S 15535, and WAY 100,635, upon the electrical activity of dopaminergic neurons in the ventral tegmental area (VTA), as compared to serotonergic neurons in the dorsal raphe nucleus (DRN) of anesthetized ra